LSA
IBB icon

L & S Advisors’s iShares Biotechnology ETF IBB Stock Holding History

L & S Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76M Buy
+46,044
New +$7.91M 0.91% 45
2014
Q4 		– Sell
-75,840
Closed -$6.92M – 81
2014
Q3 		$6.92M Buy
+75,840
New +$6.66M 3.39% 5

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

L & S Advisors's IBB Position: Q2 2026 in Review

L & S Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 46,044 shares worth $8.76M. The stake represents 0.91% of the portfolio and ranks #45 among its holdings. This is a return to the name: L & S Advisors previously reported a position in IBB as recently as Q3 2014.

L & S Advisors first reported a position in IBB in Q3 2014 and has held it in 2 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • L & S Advisors held 46,044 shares of iShares Biotechnology ETF worth $8.76M as of Q2 2026.
  • iShares Biotechnology ETF was a new L & S Advisors position in Q2 2026.
  • iShares Biotechnology ETF made up 0.91% of L & S Advisors's portfolio in Q2 2026, its #45 holding.
  • L & S Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 2 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on L & S Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.